| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |